Oaktree Acquisition Corp. II (OACC) Stock Analysis

What Oaktree Acquisition Corp. II does

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Key metrics

ETFs linked to OACC

Broad-market and Financial Services sector ETFs an investor holding Oaktree Acquisition Corp. II is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how OACC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Oaktree Acquisition Corp. II?

Oaktree Acquisition Corp. II trades under the ticker OACC on NASDAQ.

Which exchange is OACC listed on?

OACC is listed on NASDAQ.

What sector does Oaktree Acquisition Corp. II operate in?

Oaktree Acquisition Corp. II is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze OACC in a portfolio?

PortView shows OACC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.